Cargando…
Population pharmacokinetic analysis of TQ-B3203 following intravenous administration of TQ-B3203 liposome injection in Chinese patients with advanced solid tumors
Background: TQ-B3203 is a novel topoisomerase I inhibitor currently in development for the treatment of advanced solid tumors. Great differences in pharmacokinetic characteristics were found among individuals according to the phase I clinical trial following intravenous administration of TQ-B3203 li...
Autores principales: | Li, Xiaoqing, Bo, Yunhai, Yin, Han, Liu, Xiaohong, Li, Xu, Yang, Fen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885713/ https://www.ncbi.nlm.nih.gov/pubmed/36726585 http://dx.doi.org/10.3389/fphar.2023.1102244 |
Ejemplares similares
-
Population Pharmacokinetic Modeling and Simulation of TQ-B3101 to Inform Dosing in Pediatric Patients With Solid Tumors
por: Yang, Fen, et al.
Publicado: (2022) -
3203 Collaboration in Reappointment, Promotion, and Tenure Guidelines
por: Knapke, Jacqueline, et al.
Publicado: (2019) -
Rare top quark production in ATLAS ($t\bar{t}t\bar{t}$, $tqZ$, $tq\gamma$)
por: Sabatini, Paolo
Publicado: (2020) -
Rare top quark production in ATLAS ($t\bar{t}t\bar{t}$, $tqZ$, $tq\gamma$)
por: Sabatini, Paolo
Publicado: (2021) -
A Novel Ferroptosis Inhibitor UAMC-3203, a Potential Treatment for Corneal Epithelial Wound
por: Balla, Anusha, et al.
Publicado: (2022)